Duesseldorf, July 4, 2022 – Gerresheimer has reached another milestone in the realization of its financing strategy by signing a revolving credit facility in the amount of EUR 150m. This refinancing…
MERXIN and Gerresheimer worked successful together to realize the shortest possible time to market for the MERXIN MRX003 Capsule DPI
Wackersdorf, June 13, 2022: Gerresheimer has assumed…
Partners join forces to improve lives of millions of Parkinson’s patients worldwide with a transformative technology-based solution Gerresheimer participates in seed-round of the Finnish MedTech…
Duesseldorf, June 08, 2022 – The Annual General Meeting of Gerresheimer AG has approved the payment of a dividend of EUR 1.25 per share for the 2021 financial year. This represents a payout ratio of…
Wackersdorf, May 30, 2022: The drug development company ISR has signed an agreement with Gerresheimer for large-scale production of the IcoOne nasal inhaler, for its phase III study of its dry powder…
Container-level traceability from production to point-of-care (PoC)
Düsseldorf/Olten, May 24, 2022. The Gerresheimer traceability concept ensures complete transparency throughout the value chain and…
Düsseldorf/Kosamba, May 16, 2022. Gerresheimer has significantly ramped up its glass and plastic production capacities in India. A new modern plant to produce high quality plastic containers and…
Duesseldorf/Kosamba, May 16, 2022. Gerresheimer has significantly ramped up its glass and plastic production capacities in India to satisfy its global pharma customer needs. A new modern plant to…
Duesseldorf/Paris, May 11, 2022. Which packaging or delivery solution is best suited to the respective active ingredient? In addition to Gerresheimer's experts, the g guide has recently been…